Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Teresa R. Pacheco"'
Autor:
Marta Martins, Luís Costa, Rita Fior, André Mansinho, Ana Lucia-Costa, Catarina Abreu, Teresa R. Pacheco, Maria J. Brito, Helder Mansinho, Ana R. Miranda, Miguel Godinho Ferreira, Ana T. Xavier, José Vílchez, João Gramaça, Daniel Machado, Lina M. Gallego-Paez, Daniel Sobral, Paula Borralho, Afonso Fernandes, Magda Negrão, Cátia Rebelo de Almeida, Raquel Cruz-Duarte
Purpose:Cetuximab is an EGFR-targeted therapy approved for the treatment of RAS wild-type (WT) metastatic colorectal cancer (mCRC). However, about 60% of these patients show innate resistance to cetuximab. To increase cetuximab efficacy, it is crucia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61d133d617637977ca820648022af1b8
https://doi.org/10.1158/1078-0432.c.6531303.v1
https://doi.org/10.1158/1078-0432.c.6531303.v1
Autor:
Marta Martins, Luís Costa, Rita Fior, André Mansinho, Ana Lucia-Costa, Catarina Abreu, Teresa R. Pacheco, Maria J. Brito, Helder Mansinho, Ana R. Miranda, Miguel Godinho Ferreira, Ana T. Xavier, José Vílchez, João Gramaça, Daniel Machado, Lina M. Gallego-Paez, Daniel Sobral, Paula Borralho, Afonso Fernandes, Magda Negrão, Cátia Rebelo de Almeida, Raquel Cruz-Duarte
Supplementary Figure from Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::083ae1169e4cc776a94303306d7877c5
https://doi.org/10.1158/1078-0432.22484019
https://doi.org/10.1158/1078-0432.22484019
Autor:
Marta Martins, Luís Costa, Rita Fior, André Mansinho, Ana Lucia-Costa, Catarina Abreu, Teresa R. Pacheco, Maria J. Brito, Helder Mansinho, Ana R. Miranda, Miguel Godinho Ferreira, Ana T. Xavier, José Vílchez, João Gramaça, Daniel Machado, Lina M. Gallego-Paez, Daniel Sobral, Paula Borralho, Afonso Fernandes, Magda Negrão, Cátia Rebelo de Almeida, Raquel Cruz-Duarte
Supplementary Data from Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbf57725dac3cb782017ff755cd50cad
https://doi.org/10.1158/1078-0432.22484034
https://doi.org/10.1158/1078-0432.22484034
Autor:
Raquel Cruz-Duarte, Cátia Rebelo de Almeida, Magda Negrão, Afonso Fernandes, Paula Borralho, Daniel Sobral, Lina M. Gallego-Paez, Daniel Machado, João Gramaça, José Vílchez, Ana T. Xavier, Miguel Godinho Ferreira, Ana R. Miranda, Helder Mansinho, Maria J. Brito, Teresa R. Pacheco, Catarina Abreu, Ana Lucia-Costa, André Mansinho, Rita Fior, Luís Costa, Marta Martins
Publikováno v:
Clinical Cancer Research
Clinical Cancer Research, American Association for Cancer Research, 2022, pp.clincanres.1992.2021. ⟨10.1158/1078-0432.CCR-21-1992⟩
Clinical Cancer Research, American Association for Cancer Research, 2022, pp.clincanres.1992.2021. ⟨10.1158/1078-0432.CCR-21-1992⟩
© 2022 The Authors; Published by the American Association for Cancer Research. This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 International (CC BY-NC-ND)
Purpose: Cetuximab is
Purpose: Cetuximab is
Autor:
Sara Damaso, Allan Lipton, Luís Costa, Ana Lúcia Costa, Kim Leitzel, Teresa R. Pacheco, Kim Henriksen, Ana C Martins Cavaco, Nicholas Willumsen, Morten A. Karsdal, Ourania Tzara, Claudia C. Faria, Patrícia Corredeira, Suhail M. Ali
Publikováno v:
Journal of Clinical Oncology. 39:e14007-e14007
e14007 Background: Brain metastases (BrMs) occur frequently in patients with breast cancer (BC) and represent one of the most difficult-to-treat events. Novel clinical tools are needed to identify BC patients at high risk of developing BrMs. Blood-ba
Autor:
Teresa R. Pacheco, Ana Rita Sousa, Catarina Abreu, Catarina Pulido, Ana Lúcia Costa, Daniela Macedo, Sandra Casimiro, Irina Alho, R. Brás, Arlindo R. Ferreira, L. Costa, André Mansinho, M. F. C. Melo
Publikováno v:
Cancer Research. 76:P4-09
Background: Receptor activator of NF-kB (RANK) pathway regulates bone remodeling and is involved in breast cancer (BC) progression. RANK over-expression in primary BC associates with poor prognosis and metastasis development. In patients with BC, RAN
Autor:
Catarina Abreu, Arlindo R. Ferreira, Catarina Pulido, Daniela Macedo, Luis Costa, Teresa R. Pacheco, Ines Vendrell, Sandra Casimiro, Ana Rita Sousa, M. Bettencourt, Irina Alho, André Mansinho, Adília Costa
Publikováno v:
Journal of Bone Oncology
Journal of Bone Oncology, Vol 6, Iss C, Pp 16-21 (2017)
Journal of Bone Oncology, Vol 6, Iss C, Pp 16-21 (2017)
YB-1 (Y-box binding protein 1) is a multifunctional cold-shock protein that has been implicated in all hallmarks of cancer. Elevated YB-1 protein level was associated with poor prognosis in several types of cancers, including breast cancer (BC), wher
Autor:
Teresa R. Pacheco, Catarina Pulido, Ines Vendrell, Irina Alho, Luís Costa, Maria Bettencourt, Daniela Macedo, Arlindo R. Ferreira, Sandra Casimiro, Costa Ana Lucia, Ana Rita Sousa, Catarina Abreu, André Mansinho
Publikováno v:
Bone Abstracts.
Autor:
L. Costa, Daniela Macedo, R. Paiva, C. Melo Alvim, R. Brás, Isabel Fernandes, André Mansinho, Teresa R. Pacheco
Publikováno v:
European Urology Supplements. 17:e2871
Publikováno v:
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
© 2014 Elsevier B.V. All rights reserved.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.bbamcr.2014.11.006
Cancer remains a major cause of morbidity and mortality worldwide. Although progress has be
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.bbamcr.2014.11.006
Cancer remains a major cause of morbidity and mortality worldwide. Although progress has be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fba5b6ca28a52493a489b73a32e0dc17
https://hdl.handle.net/10451/23085
https://hdl.handle.net/10451/23085